{ "cik": 1665988, "cik_padded": "0001665988", "entityName": "Bioventus Inc.", "fiscal_years": [ { "accn": "0001665988-26-000011", "filed": "2026-03-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2562000.0, "cash": 51238000.0, "cost_of_revenue": 179930000.0, "eps_diluted": 0.33, "free_cash_flow": 72111000.0, "gross_profit": 388157000.0, "net_income": 22732000.0, "operating_cash_flow": 74673000.0, "operating_income": 53975000.0, "revenue": 568087000.0, "stockholders_equity": 184105000.0, "total_assets": 683559000.0, "total_liabilities": 455112000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6832703441550326, "leverage": 2.472024116672551, "net_margin": 0.04001499770281665, "operating_margin": 0.09501185557845894, "revenue_growth_yoy": -0.009058400781468044, "roa_avg2y": 0.032209363697870724, "roa_period_end": 0.03325535908385377, "roe_avg2y": 0.13692120043969944, "roe_period_end": 0.12347301811466282 } }, { "accn": "0001665988-26-000011", "filed": "2026-03-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1006000.0, "cash": 41582000.0, "cost_of_revenue": 185054000.0, "eps_diluted": -0.56, "free_cash_flow": 37789000.0, "gross_profit": 388226000.0, "net_income": -36125000.0, "operating_cash_flow": 38795000.0, "operating_income": -15195000.0, "revenue": 573280000.0, "stockholders_equity": 147940000.0, "total_assets": 727956000.0, "total_liabilities": 542352000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6772013675690762, "leverage": 3.66602676760849, "net_margin": -0.0630145827518839, "operating_margin": -0.02650537259279933, "revenue_growth_yoy": 0.11893353111672798, "roa_avg2y": -0.04695015680377629, "roa_period_end": -0.049625252075674905, "roe_avg2y": -0.22470617141115476, "roe_period_end": -0.24418683249966203 } }, { "accn": "0001665988-26-000011", "filed": "2026-03-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7362000.0, "cash": 36964000.0, "cost_of_revenue": 184152000.0, "eps_diluted": -2.49, "free_cash_flow": 7982000.0, "gross_profit": 328193000.0, "net_income": -156230000.0, "operating_cash_flow": 15344000.0, "operating_income": -81725000.0, "revenue": 512345000.0, "stockholders_equity": 173591000.0, "total_assets": 810910000.0, "total_liabilities": 589792000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6405703188281334, "leverage": 3.397595497462426, "net_margin": -0.30493124749924366, "operating_margin": -0.15951165718412397, "revenue_growth_yoy": 0.000445210762384377, "roa_avg2y": -0.1430966600856675, "roa_period_end": -0.19266009791468844, "roe_avg2y": -0.626386998350136, "roe_period_end": -0.8999890547321001 } }, { "accn": "0001628280-25-011831", "filed": "2025-03-11", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1478000.0, "cash": 30186000.0, "cost_of_revenue": 181037000.0, "eps_diluted": -2.59, "free_cash_flow": -15015000.0, "gross_profit": 331080000.0, "net_income": -158704000.0, "operating_cash_flow": -13537000.0, "operating_income": -167234000.0, "revenue": 512117000.0, "stockholders_equity": 325238000.0, "total_assets": 1372649000.0, "total_liabilities": 960427000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6464928912728927, "leverage": 2.952997497217422, "net_margin": -0.3098979334800446, "operating_margin": -0.326554283493811, "revenue_growth_yoy": 0.18848776276520196, "roa_avg2y": -0.12214995433923505, "roa_period_end": -0.11561877799787126, "roe_avg2y": -0.40477350343423935, "roe_period_end": -0.48796266118965187 } }, { "accn": "0001628280-24-010376", "filed": "2024-03-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13520000.0, "cash": 43933000.0, "cost_of_revenue": 128192000.0, "eps_diluted": -0.15, "free_cash_flow": 9471000.0, "gross_profit": 302706000.0, "net_income": 19375000.0, "operating_cash_flow": 22991000.0, "operating_income": 12061000.0, "revenue": 430898000.0, "stockholders_equity": 458924000.0, "total_assets": 1225862000.0, "total_liabilities": 618206000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7025003597138998, "leverage": 1.3470770759428576, "net_margin": 0.04496423747615444, "operating_margin": 0.027990382874833485, "revenue_growth_yoy": 0.34168843664081255, "roa_avg2y": 0.022524774345357396, "roa_period_end": 0.015805204827297036, "roe_period_end": 0.042218319373142396 } }, { "accn": "0001628280-23-010151", "filed": "2023-03-31", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 16579000.0, "cash": 86839000.0, "cost_of_revenue": 87642000.0, "free_cash_flow": 55220000.0, "gross_profit": 233519000.0, "net_income": 16411000.0, "operating_cash_flow": 71799000.0, "operating_income": 21237000.0, "revenue": 321161000.0, "total_assets": 494466000.0, "total_liabilities": 350306000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio" }, "ratios": { "gross_margin": 0.7271088332643129, "net_margin": 0.051098981507717314, "operating_margin": 0.06612571264879609, "revenue_growth_yoy": -0.05580038866234885, "roa_period_end": 0.033189339610812475 } }, { "accn": "0001628280-22-005816", "filed": "2022-03-11", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD" }, "fundamentals": { "capex": 2342000.0, "cost_of_revenue": 90935000.0, "free_cash_flow": 38371000.0, "gross_profit": 249206000.0, "net_income": 6851000.0, "operating_cash_flow": 40713000.0, "operating_income": 31193000.0, "revenue": 340141000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio" }, "ratios": { "gross_margin": 0.7326549871964861, "net_margin": 0.020141647140450577, "operating_margin": 0.09170608659350094 } } ], "latest_filing": { "accn": "0001665988-26-000011", "filed": "2026-03-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001665988.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001665988.json" }, "ticker": "BVS" }